KIT and acute promyelocytic leukemia: Consistent with the recent observations revealing the differentiational heterogeneity of AML LSCs,27 our cell-sorting and transplantation experiments indicated that c-Kit+ APL cells, without or with an obvious CD11b expression, both retained substantial leukemogenic potential.